Los inhibidores del SGLT-2 y los agonistas del receptor GLP-1 disminuyen la mortalidad en pacientes con diabetes mellitus tipo 2 / SGLT-2 inhibitors and GLP-1 receptor agonists decrease mortality in patients with type 2 diabetes
Evid. actual. práct. ambul
;
24(4): e002151, 2021. tab
Article
in Spanish
| LILACS, UNISALUD, BINACIS
| ID: biblio-1362014
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Diabetes Mellitus, Type 2
/
Glucagon-Like Peptide-1 Receptor
/
Sodium-Glucose Transporter 2 Inhibitors
/
Hypoglycemic Agents
Type of study:
Controlled clinical trial
/
Prognostic study
/
Systematic reviews
Limits:
Humans
Language:
Spanish
Journal:
Evid. actual. práct. ambul
Year:
2021
Type:
Article
Institution/Affiliation country:
Hospital Italiano de Buenos Aires/AR
Similar
MEDLINE
...
LILACS
LIS